Abbreviated 12-Hour Postpartum Magnesium Sulphate Therapy is Equally Effective and Safer Than Standard 24-Hour Therapy in Preeclampsia With Severe Features: Results From A Randomized Controlled Trial
Objective: Eclampsia is a major life-threatening complication of preeclampsia with severe features leading to significant perinatal and maternal mortality and morbidity. Magnesium sulphate (MgSO4) is the first-line therapy for eclampsia prevention and treatment, however, its use is associated with...
Saved in:
| Main Authors: | Pradip Kumar Saha, Seema Sheokand, L K Dhaliwal, Rashmi Bagga, Lekha Saha |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Tehran University of Medical Sciences
2025-04-01
|
| Series: | Journal of Family and Reproductive Health |
| Subjects: | |
| Online Access: | https://jfrh.tums.ac.ir/index.php/jfrh/article/view/3050 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Distribution and spatial autocorrelation of maternal mortality from preeclampsia and eclampsia in Brazil / Distribuição e autocorrelação espacial da mortalidade materna por pré-eclâmpsia e eclâmpsia no Brasil
by: Ana Maria Batista Tavares, et al.
Published: (2023-02-01) -
Effect of dexmedetomidine combined with magnesium sulphate on intracranial tension in patients with severe pre-eclampsia using ultrasonographic optic nerve sheath Diameter - A randomised clinical trial
by: Enas W. Mahdy, et al.
Published: (2025-08-01) -
Do platelet indices play a role in assessing severity of pre-eclampsia and eclampsia?
by: Priyamvada Singhal, et al.
Published: (2021-09-01) -
The pathophysiological spectrum of maternal complications of pregnancy-induced hypertension: Review Article
by: Adedeji Okikiade, et al.
Published: (2025-05-01) -
Platelet Distribution Width: A Severity Marker Of Pre Eclampsia, Experience At Tertiary Care Hospital
by: Mariam Zahir, et al.
Published: (2023-06-01)